- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02568592
Exercise Substrate Utilisation and Endurance Performance Following Short-term Manipulation of Dietary Fat Intake
11. maj 2016 opdateret af: University of Birmingham
Exercise Substrate Utilisation and Endurance Performance Following Short-term Manipulation of Dietary Fat Intake in Women
The capacity to burn fat as fuel for exercise may have important implications for sporting performance, with dietary fat intake positively influencing this ability.
Endurance performance and the ability to burn fat will be measured in women runners following the consumption of 3 diets varying in the amount of fat and carbohydrate.
Studieoversigt
Status
Ukendt
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Dietary fat intake positively influences the ability to burn fat during exercise in women but not men, whereas carbohydrate intake negatively influences fat oxidation in both sexes.
The independent nature of dietary fat intake as a predictor of the ability to burn fat in women suggests that in conditions of adequate carbohydrate intake providing additional fat may increase fat oxidation in women whereas it does not in men.
It is of interest to explore if indeed women are responsive (i.e., increase in fat oxidation) to short-term increases in dietary fat intake induced by overfeeding (adequate carbohydrate) or if as appears to be the case in men reduced carbohydrate intake as typically employed in high-fat, low carbohydrate dietary studies is also a prerequisite for enhancing fat oxidation in women, and whether this translates into a difference in exercise endurance performance.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
16
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
West Midlands
-
Birmingham, West Midlands, Det Forenede Kongerige, B15 2TT
- University of Birmingham
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 45 år (Voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Kvinde
Beskrivelse
Inclusion Criteria:
- BMI >17.0 < 25 kg/m2
- Good General Health
- Accustomed to vigorous physical activity
- Run > 2 times per week
- V̇O2max >50ml/kg/min
- Weight Stable > last 6months
- Non Smoker
- Pre-menopausal, and either eumenorrheic and regularly menstruating, or using monophasic hormonal oral contraceptives for > 3 months.
Exclusion Criteria:
- Currently taking part in another scientific/clinical study
- Taking any prescription drug / supplement thought to influence metabolism
- Following unusual dietary practices (such as intermittent fasting or low carbohydrate diets)
- Pregnant
- Breast Feeding
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: High Fat
High Fat - Carbohydrate (20%), Fat (65%), Protein (15%)
|
High Fat - Carbohydrate (20%), Fat (65%), Protein (15%)
|
|
Eksperimentel: Normal
Normal - Carbohydrate (50%), Fat (35%) and Protein (15%)
|
Normal - Carbohydrate (50%), Fat (35%) and Protein (15%)
|
|
Eksperimentel: Normal + Extra Fat
Normal + Extra Fat - Carbohydrate (50%), Fat (65%), Protein (15%).
Carbohydrate and protein intake identical in absolute amounts to NORM (Normal), with an additional 30% extra energy coming from fat.
|
Normal + Extra Fat - Carbohydrate (50%), Fat (65%), Protein (15%).
Carbohydrate and protein intake identical in absolute amounts to NORMAL, with an additional 30% extra energy coming from fat.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Rates of fat oxidation during exercise
Tidsramme: 90 minutes of sub-maximal exercise
|
Rates of fat oxidation to be measured via indirect calorimetry during 90 minutes of submaximal exercise
|
90 minutes of sub-maximal exercise
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
5km running performance
Tidsramme: Immediately following measurement of Primary Outcome measure
|
Time to complete 5km on a treadmill
|
Immediately following measurement of Primary Outcome measure
|
|
Change in plasma glucose concentration
Tidsramme: 90 minutes sub-maximal exercise
|
Area under the plasma concentration versus time curve (AUC) of glucose
|
90 minutes sub-maximal exercise
|
|
Change in Free Fatty Acid concentration
Tidsramme: 90 minutes sub-maximal exercise
|
Area under the plasma concentration versus time curve (AUC) of Free Fatty Acid
|
90 minutes sub-maximal exercise
|
|
Change in plasma glycerol concentration
Tidsramme: 90 minutes sub-maximal exercise
|
Area under the plasma concentration versus time curve (AUC) of glycerol
|
90 minutes sub-maximal exercise
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Gareth A Wallis, PhD, University of Birmingham
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. marts 2015
Primær færdiggørelse (Forventet)
1. juni 2016
Studieafslutning (Forventet)
1. juni 2016
Datoer for studieregistrering
Først indsendt
13. maj 2015
Først indsendt, der opfyldte QC-kriterier
2. oktober 2015
Først opslået (Skøn)
6. oktober 2015
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
13. maj 2016
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
11. maj 2016
Sidst verificeret
1. maj 2016
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- ERN_15-0012
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kostændringer
-
Tel Aviv UniversityAfsluttetAttention Bias Modification Treatment (ABMT)Israel
Kliniske forsøg med High Fat
-
University Psychiatric Clinics BaselIkke rekrutterer endnuDepressiv lidelse | Større depressiv lidelse | Depression, Bipolar
-
NYU Langone HealthNational Institute on Deafness and Other Communication Disorders (NIDCD)Rekruttering
-
University of PittsburghArmed Forces Institute of Regenerative MedicineRekrutteringAnsigtsfejlForenede Stater
-
Zhujiang HospitalThe First Affiliated Hospital of Anhui Medical University; Xiangya Hospital... og andre samarbejdspartnereAfsluttetKnæ slidgigt | Artropati af knæKina
-
Midwest Heart & Vascular SpecialistsRekrutteringAL Amyloidose | Amyloid | Hjerte amyloidose | Amyloidose Hjerte | Systemisk amyloidose | ATTR Amyloidose vildtype | Infiltrativ kardiomyopati, amyloidForenede Stater
-
Riphah International UniversityRekrutteringMuskelstramhedPakistan
-
Barron Associates, Inc.University of VirginiaAfsluttetVirtual reality | ErgoterapiForenede Stater
-
BravaAfsluttetMastektomi | Mammaplastik | LumpektomiForenede Stater
-
EMO Biomedicine CorporationFar Eastern Memorial HospitalAfsluttet
-
University Hospital Southampton NHS Foundation...Boston Scientific Corporation; HeartFlow, Inc.; Wessex Heartbeat; CaristoRekrutteringST Elevation MyokardieinfarktDet Forenede Kongerige